Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver

Proteomics - Clinical Applications

Volumn 4, Issue 4, 2010, Pages 394-406

  Liao, Yi Jen ^a   Chen, Kuan Hsuan ^a   Huang, Shiu Feng ^b   Chen, Tzu Lang ^a   Wang, Chung Kwe ^c   Chien, Chau Heng ^a   Tsai, Ting Fen ^a   Liu, Shih Ping ^a,d   Chen, Yi Ming Arthur ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anti oxidation; Benzo a pyrene; Detoxification; Glycine N methyltransferase; Hepatocellular carcinoma

Indexed keywords

3 HYDROXYANTHRANILATE 3,4 DIOXYGENASE; 40S RIBOSOME PROTEIN; ACTIN; ADENOSYLHOMOCYSTEINASE; ALDEHYDE DEHYDROGENASE; ALPHA ENOLASE; ARGINASE 1; BENZO[A]PYRENE; CARBONATE DEHYDRATASE III; CYTOCHROME B5; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE A3; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLYCINE METHYLTRANSFERASE; KETOHEXOKINASE; LACTOYLGLUTATHIONE LYASE; MAJOR URINARY PROTEIN 2 PRECURSOR; MALATE DEHYDROGENASE; PEPTIDYLPROLYL ISOMERASE; PEROXIREDOXIN 2; PEROXIREDOXIN 6; PROHIBITIN; PROTEIN PRECURSOR; REGUCALCIN; RIBOSOME PROTEIN; SARCOSINE DEHYDROGENASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON METABOLISM; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DETOXIFICATION; DNA ADDUCT; ENERGY METABOLISM; ENZYME DEFICIENCY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WILD TYPE;

MUS;

EID: 77953718800     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900074     Document Type: Article

References (57)

1. Blumenstein, J., Williams, G. R., The enzymic N-methylation of glycine. Biochem. Biophys. Res. Commun. 1960, 3, 259-263.
2. Kerr, S. J., Competing methyltransferase systems. J. Biol. Chem. 1972, 247, 4248-4252.
3. Chen, S. Y., Lin, J. R., Darbha, R., Lin, P. et al., Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway. Cancer Res. 2004, 64, 3617-3623.
4. Lee, C. M., Chen, S. Y., Lee, Y. C., Huang, C. Y., Chen, Y. M., Benzo[a]pyrene and glycine N-methyltransferse interactions: gene expression profiles of the liver detoxification pathway. Toxicol. Appl. Pharmacol. 2006, 214, 126-135.
5. Yen, C. H., Hung, J. H., Ueng, Y. F., Liu, S. P. et al., Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect. Toxicol. Appl. Pharmacol. 2009, 235, 296-304.
6. Chen, Y. M., Shiu, J. Y., Tzeng, S. J., Shih, L. S. et al., Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int. J. Cancer 1998, 75, 787-793.
7. Liu, H. H., Chen, K. H., Shih, Y. P., Lui, W. Y. et al., Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies. J. Biomed. Sci. 2003, 10, 87-97.
8. Huang, Y. C., Chen, M., Shyr, Y. M., Su, C. H. et al., Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma. J. Gastroenterol. Hepatol. 2008, 23, 1384-1389.
9. Liu, S. P., Li, Y. S., Chen, Y. J., Chiang, E. P. et al., Glycine Nmethyltransferase -/- mice develop chronic hepatitis and glycogen storage disease in the liver. Hepatology 2007, 46, 1413-1425.
10. Liao, Y. J., Liu, S. P., Lee, C. M., Yen, C. H. et al., Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility. Int. J. Cancer 2009, 124, 816-826.
11. Görg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
12. Wittmann-Liebold, B., Graack, H. R., Pohl, T., Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 2006, 6, 4688-4703.
13. Liang, C. R., Leow, C. K., Neo, J. C., Tan, G. S. et al., Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2005, 5, 2258-2271.
14. Sun, W., Xing, B., Sun, Y., Du, X. et al., Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics 2007, 6, 1798-1808.
15. Chaerkady, R., Harsha, H. C., Nalli, A., Gucek, M. et al., A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J. Proteome Res. 2008, 7, 4289-4298.
16. Lee, N. P., Chen, L., Lin, M. C., Tsang, F. H. et al., Proteomic expression signature distinguishes cancerous and nonma-lignant tissues in hepatocellular carcinoma. J. Proteome Res. 2009, 8, 1293-1303.
17. Codarin, E., Renzone, G., Poz, A., Avellini, C. et al., Differential proteomic analysis of subfractioned human hepatocellular carcinoma tissues. J. Proteome Res. 2009, 8, 2273-2284.
18. Luk, J. M., Lam, C. T., Siu, A. F., Lam, B. Y. et al., Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) upregulation and their associated prognostic values. Proteomics 2006, 6, 1049-1057.
19. Fujii, K., Kondo, T., Yokoo, H., Yamada, T. et al., Proteomic study of human hepatocellular carcinoma using twodimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 2005, 5, 1411-1422.
20. Li, C., Tan, Y. X., Zhou, H., Ding, S. J. et al., Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: identification of potential tumor markers. Proteomics 2005, 5, 1125-1139.
21. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Overexpression of alpha enolase in hepatitis C virusrelated hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 2005, 5, 1686-1692.
22. Blanc, J. F., Lalanne, C., Plomion, C., Schmitter, J. M. et al., Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005, 5, 3778-3789.
23. Kuramitsu, Y., Nakamura, K., Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma. Exp. Rev. Proteomics 2005, 2, 589-601.
24. Yokoyama, Y., Kuramitsu, Y., Takashima, M., Iizuka, N. et al., Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004, 4, 2111-2116.
25. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 2003, 3, 2487-2493.
26. Seow, T. K., Liang, R. C., Leow, C. K., Chung, M. C., Hepatocellular carcinoma: from bedside to proteomics. Proteomics 2001, 1, 1249-1263.
27. Kuramitsu, Y., Nakamura, K., Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers. Proteomics 2006, 6, 5650-5661.
28. Yamanaka, H., Yakabe, Y., Saito, K., Sekijima, M., Shirai, T., Quantitative proteomic analysis of rat liver for carcinogenicity prediction in a 28-day repeated dose study. Proteomics 2007, 7, 781-795.
29. Banerjee, A., Russell, W. K., Jayaraman, A., Ramaiah, S. K., Identification of proteins to predict the molecular basis for the observed gender susceptibility in a rat model of alcoholic steatohepatitis by 2-D gel proteomics. Proteomics 2008, 8, 4327-4337.
30. Esterbauer, H., Schaur, R. J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81-128.
31. Rodriguez, L. V., Dunsford, H. A., Steinberg, M., Chaloupka, K. K. et al., Carcinogenicity of benzo[a]pyrene and manufactured gas plant residues in infant mice. Carcinogenesis 1997, 18, 127-135.
32. Liska, D. J., The detoxification enzyme systems. Altern. Med. Rev. 1998, 3, 187-198.
33. Hers, H. G., Hue, L., Gluconeogenesis and related aspects of glycolysis. Annu. Rev. Biochem. 1983, 52, 617-653.
34. Obenauer, J. C., Cantley, L. C., Yaffe, M. B., Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequencemotifs. Nucleic Acids Res. 2003, 31, 3635-3641.
35. Luka, Z., Ham, A. J., Norris, J. L., Yeo, E. J. et al., Identification of phosphorylation sites in glycine N-methyltransferase from rat liver. Protein Sci. 2006, 15, 785-794.
36. Moller, M. T., Samari, H. R., Fengsrud, M., Stromhaug, P. E. et al., Okadaic acid-induced, naringin-sensitive phosphorylation of glycine N-methyltransferase in isolated rat hepatocytes. Biochem. J. 2003, 373, 505-513.
37. Bannasch, P., Hacker, H. J., Klimek, F., Mayer, D., Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv. Enzyme Regul. 1984, 22, 97-121.
38. Tien Kuo, M., Savaraj, N., Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers. Mol. Carcinog. 2006, 45, 701-709.
39. Schrader, M., Fahimi, H. D., Peroxisomes and oxidative stress. Biochim. Biophys. Acta 2006, 1763, 1755-1766.
40. Sasaki, Y., Does oxidative stress participate in the development of hepatocellular carcinoma? J. Gastroenterol. 2006, 41, 1135-1148.
41. Fang, Y. Z., Yang, S., Wu, G., Free radicals, antioxidants, and nutrition. Nutrition 2002, 18, 872-879.
42. Elchuri, S., Oberley, T. D., Qi, W., Eisenstein, R. S. et al., CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005, 24, 367-380.
43. Uthus, E. O., Brown-Borg, H. M., Methionine flux to transsulfuration is enhanced in the long living Ames dwarf mouse. Mech. Ageing Dev. 2006, 127, 444-450.
44. Pacher, P., Beckman, J. S., Liaudet, L., Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87, 315-424.
45. Hoffmann, D., Rivenson, A., Chung, F. L., Wynder, E. L., Potential inhibitors of tobacco carcinogenesis. Ann. N. Y. Acad. Sci. 1993, 686, 140-160.
46. Donato, F., Gelatti, U., Limina, R. M., Fattovich, G., Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 2006, 25, 3756-3770.
47. Chen, C. J., Yu, M. W., Liaw, Y. F., Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1997, 12, S294-S308.
48. IARC, Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog. Risks Hum. 2004, 83, 1-1438.
49. Goldstein, L. S., Weyand, E. H., Safe, S., Steinberg, M. et al., Tumors and DNA adducts in mice exposed to benzo[a]-pyrene and coal tars: implications for risk assessment. Environ. Health Perspect. 1998, 106, 1325-1330.
50. Park, S. Y., Lee, S. M., Ye, S. K., Yoon, S. H. et al., Benzo[a]pyrene-induced DNA damage and p53 modulation in human hepatoma HepG2 cells for the identification of potential biomarkers for PAH monitoring and risk assessment. Toxicol. Lett. 2006, 167, 27-33.
51. Cherng, S. H., Hsu, S. L., Yang, J. L., Yu, C. T., Lee, H., Suppressive effect of 1-nitropyrene on benzo[a]pyreneinduced CYP1A1 protein expression in HepG2 cells. Toxicol. Lett. 2006, 161, 236-243.
52. Lin, T., Yang, M. S., Benzo[a]pyrene-induced elevation of GSH level protects against oxidative stress and enhances xenobiotic detoxification in human HepG2 cells. Toxicology 2007, 235, 1-10.
53. Kushman, M. E., Kabler, S. L., Fleming, M. H., Ravoori, S. et al., Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1. Carcinogenesis 2007, 28, 207-214.
54. Arlt, V. M., Stiborova, M., Henderson, C. J., Thiemann, M. et al., Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice. Carcinogenesis 2008, 29, 656-665.
55. Martinez-Chantar, M. L., Vazquez-Chantada, M., Ariz, U., Martinez, N. et al., Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008, 47, 1191-1199.
56. -/- mouse models for hepatocellular carcinoma. Hepatology 2009, 49, 2130-2131.
57. Luka, Z., Capdevila, A., Mato, J. M., Wagner, C., A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res. 2006, 15, 393-397.